San Diego, November 26, 2025
Robbins Geller Rudman & Dowd LLP has filed a class action lawsuit against Perrigo Company plc, alleging violations of the Securities Exchange Act of 1934 related to misleading statements about its infant formula business. The lawsuit affects investors who acquired Perrigo securities within the specified class period. Investors have until January 16, 2026, to seek lead plaintiff status. The case emerged after Perrigo’s significant stock decline following alarming financial disclosures.
San Diego, CA – Robbins Geller Rudman & Dowd LLP Announces Class Action Lawsuit Against Perrigo Company plc
San Diego, CA – Robbins Geller Rudman & Dowd LLP has initiated a class action lawsuit against Perrigo Company plc (NYSE: PRGO), alleging violations of the Securities Exchange Act of 1934. The lawsuit targets investors who purchased or acquired Perrigo securities between February 27, 2023, and November 4, 2025. Investors have until January 16, 2026, to seek appointment as lead plaintiff in the case, titled French v. Perrigo Company plc, No. 25-cv-09596 (S.D.N.Y.).
The complaint alleges that during the specified period, Perrigo and certain executives made false and misleading statements regarding the company’s infant formula business. Specifically, the lawsuit claims that Perrigo failed to disclose significant underinvestment in maintenance and operational improvements, leading to substantial capital and operational expenditures beyond the company’s stated cost estimates. Additionally, the complaint alleges that manufacturing deficiencies in the infant formula facility resulted in overstated financial results, including earnings and cash flow.
On November 5, 2025, Perrigo announced a strategic review of its infant formula business, including reassessing a previously announced investment of $240 million. The company also revised its fiscal year 2025 outlook, citing “infant formula industry dynamics” as the primary reason for the adjustments. Following this announcement, Perrigo’s stock price declined by 25.2%, closing at $15.10 per share on November 5, 2025.
Investors who suffered substantial losses during the class period and wish to serve as lead plaintiff are encouraged to contact Robbins Geller Rudman & Dowd LLP. The firm specializes in securities class action litigation and has a history of representing investors in complex securities cases.
Frequently Asked Questions (FAQ)
What is the class action lawsuit against Perrigo Company plc about?
The class action lawsuit alleges that Perrigo Company plc and certain executives violated the Securities Exchange Act of 1934 by making false and misleading statements regarding the company’s infant formula business, leading to significant financial losses for investors.
Who is eligible to participate in the class action?
Investors who purchased or acquired Perrigo securities between February 27, 2023, and November 4, 2025, are eligible to participate in the class action. Those who suffered substantial losses during this period may seek appointment as lead plaintiff.
What is the deadline to seek appointment as lead plaintiff?
The deadline to seek appointment as lead plaintiff in the class action lawsuit is January 16, 2026.
How can I contact Robbins Geller Rudman & Dowd LLP?
Investors interested in serving as lead plaintiff or seeking more information can contact Robbins Geller Rudman & Dowd LLP through their website or by phone. Specific contact details are available on the firm’s official website.
Key Features of the Class Action Lawsuit
| Feature | Description |
|---|---|
| Defendants | Perrigo Company plc and certain executives |
| Allegations | False and misleading statements regarding the infant formula business, leading to financial losses |
| Class Period | February 27, 2023, to November 4, 2025 |
| Lead Plaintiff Deadline | January 16, 2026 |
| Stock Price Impact | Declined by 25.2%, closing at $15.10 per share on November 5, 2025 |
Deeper Dive: News & Info About This Topic
HERE Resources
